Home › Funds › MATRIX ASSET ADVISORS INC/NY › ABBV

MATRIX ASSET ADVISORS INC/NY position in ABBV

ABBVIE INC · Health Care

MATRIX ASSET ADVISORS INC/NY reported holding 33,896 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$8.9M, representing 0.73% of its reported portfolio and ranking #42 among its reported holdings. MATRIX ASSET ADVISORS INC/NY has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)33.90K sh
Reported value held$8.87M
Portfolio Weight0.73%
First reportedQ3 2023
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How MATRIX ASSET ADVISORS INC/NY's ABBV position evolved

MATRIX ASSET ADVISORS INC/NY first disclosed a stake in ABBV in Q3 2023 at 161,302 shares (US$24.0M). The position peaked in Q1 2024 at 142,956 shares, worth US$26.0M. Across 13 filings, MATRIX ASSET ADVISORS INC/NY increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 33,896 shares valued at US$8.9M — a reduction of -5,174 shares quarter over quarter.. Notable position changes include a 30% trim in Q3 2024 (shares fell 9% over the following quarter), a 62% trim in Q1 2025 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 161.30K $24.04M New
Q4 2023 164.43K $25.48M Add
Q1 2024 142.96K $26.03M Reduce
Q2 2024 145.25K $24.91M Add
Q3 2024 101.26K $20.00M Reduce
Q4 2024 104.03K $18.49M Add
Q1 2025 39.12K $8.20M Reduce
Q2 2025 38.51K $7.15M Reduce
Q3 2025 38.81K $8.99M Add
Q4 2025 38.28K $8.75M Reduce
Q1 2026 39.17K $8.52M Add
Q2 2026 39.07K $9.83M Hold
Q3 2026 33.90K $8.87M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has MATRIX ASSET ADVISORS INC/NY held ABBV?

MATRIX ASSET ADVISORS INC/NY has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MATRIX ASSET ADVISORS INC/NY's current position in ABBV?

As of Q3 2026, MATRIX ASSET ADVISORS INC/NY holds 33.90K shares of ABBV (ABBVIE INC), valued at $8.87M, representing 0.73% of its reported portfolio and ranking #42.

Has MATRIX ASSET ADVISORS INC/NY been buying or selling ABBV?

In the latest 13F filing (Q3 2026), MATRIX ASSET ADVISORS INC/NY reduced its position in ABBV. The position peaked in Q1 2024 at 142.96K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.